We commercialized an innovative technology platform that detects and tracks glaucoma better than currently available tests. Medicare reimbursement is in place for the first product. Our proprietary technologies image biological structures at the back of the eye by non-invasively looking through the eye. Loss of the nerve fibers is non-reversible.
Early diagnosis drives better treatment options for doctors and patients.
We developed and now market a device that is recognized as an emerging standard for glaucoma detection - a proprietary ocular nerve fiber imaging tool. Our proprietary technology is a confocal laser-scanning ophthalmoscope with an integrated polarimeter. Our instruments employ a low-power laser beam that measures the retinal nerve fiber layer through an undilated pupil in less than one second. Polarized light is projected into the eye and as this light passes through the nerve fiber layer tissue it is changed and slowed so detectors measuring the change can calculate the nerve fiber layer thickness. Many eye care professionals currently depend on our technology as an essential diagnostic tool to detect and track glaucoma.